Prophylactic heparin in palliative care: A cautious welcome…

BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7543.728-b (Published 23 March 2006) Cite this as: BMJ 2006;332:728
  1. Victor Pace, consultant in palliative medicine (v.pace@stchristophers.org.uk),
  2. Emma Hal, consultant in palliative medicine,
  3. Catherine Bailey, specialist registrar
  1. St Christopher's Hospice, London SE26 6DZ

    EDITOR—Although we agree with the conclusions of the survey reported by Noble et al of patients' views on receiving low molecular weight heparin in palliative care, we wish to sound some notes of caution.1 Reasons other than preciousness about patients' comfort lie behind a reluctance to give many patients in palliative care prophylactic treatment with low molecular weight heparin.

    In advanced cancer …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription